• Demand for recreational cannabis has outpaced supply in Canada
• City View Green is retrofitting a 40,000-square-foot building to the highest standards for premium growth and extraction
• The company has secured a master grower and expert extraction team to grow high-quality flower and produce superior-grade cannabis extracts

City View Green Holdings Inc. (CSE: CVGR) is a vertically integrated cannabis company focused on seed-to-retail offerings. The company’s goal is to be a leading purveyor of medicinal and recreational cannabis while providing the most comprehensive and customer-centric user experience and creating a well-diversified company capable of producing long-term results.

The demand for what CVGR offers within the recreational market in Canada alone has outpaced the supply. Only one month following legalization in Canada, consumers were warned to expect cannabis products to be sold out across the country (http://ibn.fm/O27o4). According to ArcView Market Research, the recreational market is estimated to be valued at $3 billion by 2021, achieving a projected compound annual growth rate of 78 percent from 2018 to 2021. Deloitte suggests that cannabis may outsell the combined beer, wine and spirits industry, while a potential economic impact of both medical and recreational is forecast to reach over $22 billion (http://ibn.fm/L2FoL).

CVGR is working within this quickly growing industry to help curate the cannabis experience for the recreational market consumer and provide guidance for established and new retailers. CVGR sees a strong future in recreational cannabis products and is positioned to produce high-quality edibles, distillates and water-soluble products for the beverage market. Having secured a master grower, the company will be growing a high-quality crop to create its own superior-grade cannabis extracts.

A 40,000-square-foot growing facility is in the planning stages in Brantford, Ontario. The property is being retrofitted to the highest standards for premium grow operations, which includes state-of-the-art LED lighting, HVAC, dehumidification systems and automation technologies. A 4,000-square-foot extraction lab will feature an ultra-efficient CO2 supercritical extraction process. The chosen supercritical fluid extraction equipment offers proven consistent results and the highest yields, with no degradation of materials.

“The equipment we have selected has been successfully used for a quarter century in fluid extraction, and their methods have been applied to over 600 natural oils and compounds from over 300 different bio-botanical raw materials,” Mike Hagopian, CVGR’s chief operations officer and extraction guru, stated in a news release. “We are very confident this equipment will establish us as a leader in the processing of high-quality THC and CBD extracts.”

While other companies focus mainly on crop yield, CVGR is also working to lower production costs while creating and refining extraction and processing methodologies. Utilizing the skill of a master grower and an expert extraction team, the company is focused on providing superior-grade cannabis products that utilize the entire plant, making the multitude of experiential and healing modalities that it offers readily available to consumers.

CVGR is focused on providing quality every step of the way. Utilizing premium growing operations and the highest-quality fluid extraction equipment, the company is committed to offering superior products to the consumer.

For more information, visit the company’s website at www.CityViewGreen.ca

NOTE TO INVESTORS: The latest news and updates relating to CVGR are available in the company’s newsroom at http://ibn.fm/CVGR

• Nabis Holdings is a private equity play with global ambitions in the cannabis space
• The company has cannabis investments in Arizona, Michigan and Washington
• INNPF’s management team boasts a track record of boosting valuations

With the establishment of Nabis Holdings (CSE: NAB) (OTC: INNPF) (FRA: 71P), Shay Shnet and Mark Krytiuk seem set for an encore. The pioneering pair are co-founders of MPX Bioceutical (CSE: MPX) and played important roles prior to its merger with iAnthus Capital Holdings Inc. (OTCQX: ITHUF), valued at C$835 million. Now, Shnet and Krytiuk are out to repeat that success with Nabis Holdings, an aptly named investment entity; the name means “repeat performance.” Nabis is targeting vertically integrated cannabis companies with positive EBITDA that are operating in limited license states with large addressable markets.

MPX Bioceutical was founded by Shnet and Krytiuk to focus on developing and operating assets across the global cannabis industry. Shnet, with two decades of experience in senior management roles under his belt, served as vice president of operations and led the company’s efforts to build a portfolio of international cannabis assets. He is especially adept in unearthing unique investment opportunities and has been directly involved with the development, branding, importing, consumer packaging and distribution of a wide variety of product lines. Mark Krytiuk was vice president of grow operations at MPX Bioceutical and, in that position, supervised the production of medical marijuana and pharma-grade products across North America. Moreover, he has been directly involved in the construction of nine cannabis facilities in three different countries, with budgets ranging up to $30 million.

The dynamic duo has already set the ball rolling. Nabis has executed binding letters of intent (LOI) to invest in the states of Michigan, Arizona and Washington. In Michigan, Nabis plans to invest in seven strategically located properties that have or are eligible for municipal approvals as provisioning centers. In addition, the company plans to acquire a municipally approved property with 10 cultivation licenses and one processing license.

In Arizona, Nabis has executed a binding LOI to acquire full control of Organica Patient Group Inc. (“OPG”) and RDF Management Group (“RDF”). OPG is a fully-integrated medical marijuana business licensed under the provisions of the Arizona Medical Marijuana Act. Its operations include the Chino Valley MMJ Dispensary, a 26,000 square foot indoor cultivation and processing center and a 56,600 square foot greenhouse. OPG has its own branded products and an extensive distribution network that covers more than 25 percent of dispensaries in Arizona.

In Washington, Nabis plans to purchase assets from PDT Technologies LLC (“PDT”), which include extraction and production equipment and rights to lease a current production facility. With the acquisition, Nabis will enjoy licensing rights to produce Chong’s Choice Brand CO2 Vape Cartridges, one of the leading and most recognizable brands in the cannabis space.

On completion of its proposed acquisitions, Nabis is shooting for revenues of C$12 million in 2019 and C$116 million by 2020, at a gross margin of 55 percent. Expected EBITDA is forecast at C$3.3 million for 2019 and C$39.4 million for 2020.

For more information, visit the company’s website at www.NabisHoldings.com

NOTE TO INVESTORS: The latest news and updates relating to INNPF are available in the company’s newsroom at http://ibn.fm/INNPF

• A zoning settlement for the company’s cannabis greenhouse in Ontario is finalized and approved
• The company’s supply agreement with British Columbia has been signed
• TGOD entered the U.S. market through a cornerstone investment in Califormulations LLC
• The company will release first quarter 2019 earnings results after market close on May 14, 2019, and will hold a webcast before market open on May 15, 2019

The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) seems to have all the right boxes ticked as it pursues a relentless quest to become the world’s leading provider of organic cannabis. Licensed under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”), the Hamilton, Ontario-based company has a planned global capacity of 219,000kg and is building 1,643,000 sq. ft of cultivation and processing facilities across Canada and Jamaica, with the option to expand further in Denmark. That planned production moved closer to actuality after the company got the green light for its proposed greenhouse in Ancaster, Ontario. Product cultivated in this new facility likely won’t stay in inventory for long. TGOD recently signed a supply agreement with the British Columbian government, in addition to the company’s next move, entering the U.S. CBD beverage market. TGOD plans to release its first quarter 2019 earnings results after market close on May 14, 2019, and it will host an earnings call on May 15, 2019, at 9:00 am ET (http://ibn.fm/o6ICV).

TGOD has confirmed that it has finalized and signed a settlement offer with the Hamilton City Council, which was approved by the Local Planning Appeal Tribunal at a meeting on May 2, 2019 (http://ibn.fm/5ZIpf). Its proposed greenhouse in Ancaster, Ontario, designed for the production of premium certified organic cannabis, will have an annual capacity of 17,500kg. Lying close to Niagara, Ancaster is known for its easily accessible water power, which makes electricity generation relatively inexpensive. The company has an agreement with Eaton Corp., the $36 billion global power management company, under which Eaton, by providing research and optimization, will allow TGOD to have some of the lowest electricity input costs in the business. As a result, the Ontario facility is expected to produce at a power rate of $0.045 k/Wh, while the Quebec operation will produce at a power rate of $0.035 k/Wh.

The company has already secured the Ontario market. Earlier this year, TGOD signed an agreement with the Ontario Cannabis Retail Corporation (“OCRC”) (http://ibn.fm/bl0n6). The OCRC is a Canadian Crown corporation, established to be a monopoly, which operates the only legal online store for recreational cannabis in Ontario. The OCRC is set to become the wholesaler of cannabis for private retail stores in the province of Ontario.

TGOD has signed a similar deal with the government of British Columbia (http://ibn.fm/h5QJG). The company recently announced a cannabis supply agreement with the British Columbia Liquor Distribution Branch (“BCLDB”). The BCLDB, under the brand ‘BC Cannabis Stores’, is British Columbia’s public retailer of non-medical cannabis. “To negotiate the agreement, TGOD partnered with Velvet Management Inc., a wholly owned subsidiary of Phillipe Durand Wines, one of Canada’s prominent wine distributors. Velvet Management, through Phillipe Dandurand Wines, provides TGOD with national sales and distribution capabilities to provincial liquor and cannabis boards.”

TGOD has also announced its entry into the U.S. beverage market (http://ibn.fm/4BS1D). “The Company has established a joint partnership, Califormulations LLC, with Symrise AG, a global supplier of a global supplier of fragrances, flavorings, raw materials, as well as functional & cosmetic active ingredients.” The new subsidiary, which will be based in Columbus, Georgia, will provide global branded companies with concept-to-shelf beverage commercialization support, including formulation development, technical services, in-house pilot scale production and contract manufacturing coordination. Califormulations will also expedite and facilitate the U.S. launch of TGOD-branded organic hemp-based CBD beverages.

For more information, visit the company’s website at www.TGOD.ca

NOTE TO INVESTORS: The latest news and updates relating to TGODF are available in the company’s newsroom at http://ibn.fm/TGODF

• LXRP recently added multiple highly respected experts to its scientific advisory board
• The company is readying for growth by ensuring executive continuity
• LXRP continues to conduct research regarding oral nicotine

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) has bolstered its future growth prospects by adding four new members to its scientific advisory board and renewing executive contracts with three-year compensation deals for key officers, including CEO Chris Bunka and President John Docherty. The agreements and new advisory board team members offer LXRP and its shareholders seamless executive continuity (http://ibn.fm/oBuUZ).

New members of LXRP’s scientific advisory board include (http://ibn.fm/KSdJ3):

• Dr. Dwayne Godwin, dean of the graduate school and professor in the Departments of Neurobiology and Anatomy at the Institute for Regenerative Medicine at Wake Forest University;
• Dr. Terry D. Blumenthal, professor of psychology and neuroscience at Wake Forest University;
• Dr. Matthew Fraser, an associate professor and director of basic science research in the Department of Surgery, Division of Urology, at Duke University Medical Center; and
• Dr. Carla Lema Tome, an industry consultant and adjunct assistant professor of neurobiology and anatomy at Wake Forest University School of Medicine.

“Lexaria Bioscience Corp. is very pleased to welcome these accomplished experts to our Advisory Board,” Bunka stated in a news release. “[They] can provide critical scientific guidance to Lexaria’s ongoing and future R&D programs. Lexaria is building towards becoming one of the world’s leaders in drug delivery technology, and our most recent advisors can assist in achieving that goal.”

In addition, the new three-year executive agreements offer both Bunka and Docherty compensation and bonuses based on meeting certain performance criteria, as established by LXRP’s board.

Based in British Columbia, Canada, LXRP is a biotechnology company and drug-delivery platform innovator. DehydraTECH is the company’s proprietary absorption technology platform. LXRP has developed and out-licenses its disruptive technology, which promotes healthier ingestion methods and lower overall dosing. LXRP is conducting research for DehydraTECH’s potential applications for oral nicotine absorption (http://ibn.fm/HGStA). LXRP holds a patent for oral delivery of all cannabinoids.

For more information, visit the company’s website at www.LexariaBioscience.com

NOTE TO INVESTORS: The latest news and updates relating to LXRP are available in the company’s newsroom at http://ibn.fm/LXRP

• Cannabis Strategic Ventures is dedicated to supporting entrepreneurial growth in California’s cannabis industry through acquisitions and partnerships
• California’s cannabis industry is the world’s largest market for the plant’s products, with expected sales revenues of $7.7 billion by 2022
• NUGS subsidiary Asher House gained prominent media attention this month after an appearance on the Ellen DeGeneres show

California’s pioneering entry into the medical cannabis and recreational marijuana industries continues to attract challenges, as exemplified through recent concerns over an expected supply shortage when some 10,000 cultivators’ temporary state licenses expired at the end of April (http://ibn.fm/pRWVF).

As California’s legal infrastructure struggles to find a solution to keep businesses operating legally and to stave off costly lawsuits, companies such as Los Angeles-based Cannabis Strategic Ventures Inc. (OTC: NUGS) that have placed a priority on holding licenses that keep them in the state’s good graces are positioned to weather the regulatory storms with a corporate calm that allows them to focus all of their efforts on core mission fundamentals.

NUGS’ year began with announcements that it would partner with a Santa Barbara County cultivator that holds about 40 commercial cannabis licenses (http://ibn.fm/Pl02v) and that NUGS has also garnered over 20 licenses for cannabis cultivation, manufacturing and distribution, allowing it to proceed with breaking ground on a six-acre Northern California canopy cultivation site known as The NUGS Farm (http://ibn.fm/R5Vux), establishing a presence for the company at both ends of the state.

“Establishing The NUGS Farm and securing these licenses are significant milestones for Cannabis Strategic Ventures,” CEO Simon Yu stated in a news release. “We are proud of what we have accomplished at this stage of the company. As the cannabis industry expands, and as we work to make cannabis legal on a federal level, Cannabis Strategic Ventures will be in position to touch on all areas of cannabis production.”

Cannabis Strategic Ventures is focused on supporting entrepreneurial growth within the legal cannabis sector, which has gained an explosive degree of popularity and social awareness in North America during recent years. The company is building a portfolio of varied subsidiaries and, in February, gained a boost to that end from an investment of up to $3 million from a university student initiative known as Triton Funds, announced as effective once an upcoming S1 registration statement is completed.

One company subsidiary benefitted in April from significant media attention after Luke Barton and Lee Asher of the Asher House shelter dog adoption enterprise appeared on the Ellen DeGeneres show and were honored for their efforts to help pets find homes, receiving a $10,000 check from DeGeneres’ ally, ShutterFly Inc. (http://ibn.fm/uLlAH), as well as news coverage following the appearance (http://ibn.fm/5x4Ym). Asher House joined the Cannabis Strategic Ventures team last year when NUGS acquired a controlling interest in Asher House’s Pet CBD line of hemp-derived cannabidiol supplements (http://ibn.fm/vwvvo).

California remains the world’s largest cannabis market, and researchers at BDS Analytics forecast that sales of cannabis will hit $5.1 billion this year in the state (http://ibn.fm/Zw6Y0). Continuing this trend, Cannabis Business Plan analysts predict that the state industry will reach $7.7 billion in annual revenues by 2022 (http://ibn.fm/WhCUE).

For more information, visit the company’s website at www.CannabisStrategic.com

NOTE TO INVESTORS: The latest news and updates relating to NUGS are available in the company’s newsroom at http://ibn.fm/NUGS

• Cannabis sales in California, the world’s largest market, are expected to reach $7.7 billion by 2022, with an extended economic impact of almost $15 billion
• TransCanna Holdings has established the beginnings of a statewide California distribution network with its hub in Modesto and a satellite near San Bernardino and Los Angeles
• The company is rapidly pursuing a variety of state and local licenses for the facilities as part of a plan to provide up to 15 “reliable, consistent branded products”
• TransCanna’s in-process acquisition of marketing agency GoodFellas will provide it with brands that include the already competitive pre-rolls of Daily Cannabis Brands, which the company expects to distribute from its satellite facility

TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) is continuing its explosive burst of cannabis distribution empire building efforts, launched when it completed its IPO on the Canadian Securities Exchange in January. In addition to its April acquisition of a three-story, 196,000-square-foot Northern California facility that will serve as the hub for its operations, TransCanna is sub-leasing a 10,000-square-foot satellite facility in the Southern California city of Adelanto, as well as pursuing the necessary licensing and increasing its portfolio of brands.

“As we’ve represented since the commencement of TransCanna, it’s crucial to have a main facility, which we now have with the acquisition of the 196,000 square foot vertically integrated facility in Modesto, and up to five satellite facilities located strategically throughout the state,” CEO Jim Pakulis stated in a news release (http://ibn.fm/46TFg). “This is in preparation for TransCanna to provide our clients with up to fifteen reliable, consistent branded products in a timely manner. In order to do that to scale, we needed to have a significant size nursery, grow, manufacturing, bottling, baking, extracting, and transportation and distribution facility and satellite offices, which we now have.”

The Adelanto facility has existing armed guards in place for security and a four-year lease on terms of $2 per square foot per month. Its Southern California location gives it easy access to the San Bernardino and Los Angeles regions. The company is rushing to get its state and city licenses for the facility in place as soon as possible, and it announced at the close of April that it had begun the application process for a permanent manufacturing, distribution and transportation license (http://ibn.fm/vJbDo).

TransCanna expects to announce developments for the Modesto facility in the coming days, including license applications and decisions on who will serve in day-to-day leadership roles (http://ibn.fm/o6YVB).

When TransCanna began the process of acquiring full-service cannabis advertising and marketing agency GoodFellas Group LLC in January, the company already had 23 branding agreements in place (http://ibn.fm/5tE5I). Its acquisition of GoodFellas added another brand that has already established consumer demand and ‘SKU velocity’ – Daily Cannabis Goods, also known simply as the Daily brand.

“The Daily brand has seen a steady consistent increase in sales since it commenced in August 2018,” Pakulis added (http://ibn.fm/k5Rr7). “The first month shipments of units exceeded 2,100 and by December the number of units shipped for the month exceed 10,000. We anticipate closing the acquisition of GoodFellas by May 20th, and then we’ll budget accordingly in order to work on increasing units sold.”

TransCanna plans to begin by adding three more SKUs once the acquisition is complete. The Daily pre-rolls will be prepared and packaged at the Adelanto facility and delivered to dispensaries without the need for a third-party distributor.

“Our goal is to provide not only the Daily Cannabis Brand with the necessary resources to continue and grow, but to use the Adelanto facility as the first TransCanna satellite distribution network facility throughout the state in an effort to provide reliability, consistency and quality to the dispensaries, and just as importantly scale TransCanna’s ecosystem as expeditiously as possible,” Pakulis continued.

California is currently the world’s largest cannabis industry market. Research firm Cannabis Business Plan forecasts that California’s cannabis market will reach $7.7 billion in annual revenues by 2022, with a total economic impact of nearly $15 billion in the next four years (http://ibn.fm/hM5qd).

For more information, visit the company’s website at www.TransCanna.com

NOTE TO INVESTORS: The latest news and updates relating to TCAN are available in the company’s newsroom at http://ibn.fm/TCAN

• CIIX recently became the first Chinese company to sell CBD products in the United States
• The company launched a pop-up kiosk in the Glendale Galleria Mall to sell industrial hemp/CBD products
• CIIX recorded an 80 percent YOY increase in Q3 fiscal 2019 sales numbers

ChineseInvestors.com Inc. (OTCQB: CIIX), having established itself as a leading financial information website for Chinese-speaking investors in the United States and China, recognized unprecedented opportunities in the U.S. cannabis industry. Seeing that opportunity, CIIX began laying the groundwork to capitalize on the growing demand for cannabidiol (CBD)-based nutrition and health products. In doing so, CIIX became the first Chinese company to sell CBD products in the United States.

The company’s wholly owned subsidiary, ChineseHempOil.com Inc., has been doing business as Chinese Wellness Center (“CWC”) in the United States since 2017. The company specializes in the promotion and sales of high-end nutritional supplements and CBD hemp oil.

In a recent press release (http://ibn.fm/EaSpz), CIIX announced the launch of a pop-up mall kiosk in Glendale, California, through CWC. The kiosk began selling industrial hemp/CBD products on May 1, 2019. Products being offered include CWC’s own OptHemp product line, as well as NuLeaf Naturals, Joy Organics, Medterra, Hemp Meds and Medix.

“We are excited to bring our brand directly to the shoppers in the Greater Los Angeles area,” CIIX CEO Warren Wang stated in a news release. “Building on the current success of CWC’s industrial hemp/CBD product offerings, this pop-up kiosk will allow us to further engage with our local consumers beyond our online presence.”

CIIX is dedicated to the education of its customers and offers only the best products and solutions as it continues to expand its reach and educational awareness to the Chinese-speaking community. The company’s vision for excellence, along with its ability to identify and act on value-enhancing opportunities while providing the highest quality service to accommodate consumers’ needs, is what drives CIIX’s success.

For the third quarter of fiscal 2019, the company reported record revenues. An 81 percent year-over-year gain, totaling $1,444,822 in revenues, was attributed to a large increase in industrial hemp and CBD product sales.

“Our financial performance and highlights for the quarter are a testament to the popularity and demand for our CBD and hemp products,” Wang stated in a news release (http://ibn.fm/uzsTb). “As a result, we continue to make significant progress in our business through our investments intended to grow the platform for our consumer product lines.”

For more information, visit the company’s website at www.ChineseInvestors.com

NOTE TO INVESTORS: The latest news and updates relating to CIIX are available in the company’s newsroom at http://ibn.fm/CIIX

• Lithium is a key component in green energy storage technologies, including the batteries used in electric cars
• Significant spodumene-bearing pegmatite is located on the Irgon lithium mine project
• The global lithium-ion battery market is expected to exceed $60 billion by 2024

Global lithium market demand has been making headlines recently as industry leaders and governments shift away from fossil fuels. Most consumers are familiar with rechargeable lithium-ion batteries, which make it possible to power vehicles from renewable sources of energy. It’s a topic in which Canadian-based mineral explorer QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX.V: QMC) (FSE: 3LQ) is fully immersed, as its team of experts continues to develop a NI 43-101-compliant resource estimate for commercial production of lithium at its Irgon lithium mine project in southeastern Manitoba. Excellent access to well-developed mining infrastructure at the company’s wholly owned Irgon lithium mine project offers significant value and aids the company in ramping up the near-term production schedule (http://ibn.fm/hd7tW).

QMC recently completed an 18-hole, 2,300-meter diamond drill program on the Irgon Dike. The core was split with samples subsequently shipped to SGS Canada’s Lakefield laboratory for assay of lithium, beryllium, rubidium, cesium, tantalum, niobium and 50 other elements (http://ibn.fm/emwDe).

QMC also recently reported that assays of surface chip samples from its Mapetre, Central and Irgon West Dikes, also located within the Irgon lithium mine project, indicated significant occurrences of spodumene-bearing pegmatite mineralization (http://ibn.fm/DumIv). The Best result from these assays, from the Irgon West Dike, returned a very impressive 2.79 percent Li2O over seven meters

“An exploration program consisting of overburden stripping and channel sampling of the mineralized dikes is being planned for the upcoming field season to fully define the width, strike length and lithium grade of these dikes,” President and CEO Balraj Mann stated in an April 24 news release (http://ibn.fm/jonak).

A recent report by Global Market Insights projects that the global lithium ion battery market will surpass $60 billion by 2024 as the growing adoption of electric vehicles, coupled with government initiatives to promote sustainable, green technology, boosts the lithium sector (http://ibn.fm/ogj05). An increase in demand for smart devices, which also depend on lithium-ion batteries, is another factor in the market’s upward growth, according to the report summary.

QMC’s holdings not only include title to the Irgon lithium mine project; the company is also the owner of two volcanic massive sulphide (“VMS”) properties – the Rocky Lake and Rocky-Namew properties, known collectively as the Namew Lake District Project. The Namew Lake District Project has strong potential to host a major copper, nickel, gold, silver, palladium and platinum deposit. This project, located in northwestern Manitoba, encompasses 57,000 acres. It is situated within the Flin Flon/Snow Lake VMS mining district, one of the world’s most productive base metal, VMS mining areas (http://ibn.fm/1L873).

For more information, visit the company’s website at www.QMCMinerals.com

NOTE TO INVESTORS: The latest news and updates relating to QMCQF are available in the company’s newsroom at http://ibn.fm/QMCQF

• The company excels at cultivation and works to control its own supply chain in order to ensure certified organic products and quality for hemp-derived CBD and marijuana
• Green Hygienics Holdings’ mission is to provide best-in-class medical and recreational consumers with premier cannabis products

A full-scope, premium cannabis cultivation business, Green Hygienics Holdings Inc. (OTCQB: GRYN) is establishing itself as a leader in the advancement of science-driven cannabis cultivation systems. The company’s goal is to provide medical and recreational consumers with the best possible product and experience.

Green Hygienics recently announced that it has secured licenses for the cultivation and processing of hemp in the state of Michigan (http://ibn.fm/tv2V9). These licenses were granted to its two wholly owned subsidiaries, Green Hygienics Michigan LLC and Coastal Labs Michigan LLC. The licenses were granted under the Michigan Department of Agricultural and Rural Development (“MDARD”) Industrial Hemp Ag-Pilot Program launched by Governor Gretchen Whitmer.

“Obtaining these licenses is complementary to our mission of becoming a leader in the advancement of science-driven cannabis cultivation systems,” Green Hygienics’ VP of Business Development Matt Dole said in a news release. “Michigan’s strong farming community produces 300 different commodities on a commercial basis, and we are pleased to be part of its continued growth.”

The company’s long-term goals include expanding its portfolio of brands, first across the United States and then worldwide. Green Hygienics Holdings has its corporate headquarters in Poway, California.

Green Hygienics Holdings’ operational strategy is grouped into four levels.

• The first level is cultivation, and this is where the company excels in both hemp and marijuana cultivation. The company’s science team is made up of an extraordinary group with years of experience. They ensure certified organic products and quality for hemp-derived CBD (cannabidiol) and marijuana. Green Hygienics is using the advantages of hybrid aeroponics to create a sterile growing environment, which produces consistent, high-quality product while maintaining the lowest possible carbon footprint. The company has integrated and is developing its own IP (intellectual property) assets related to proprietary systems and apparatus, software, algorithms and custom-engineered hardware. The result is definitive efficiencies in a commercially controlled cultivation environment. Leveraging hybrid aeroponics, Green Hygienics uses high-tech, quality-controlled commercial cultivation methodologies to assure production of pharmaceutical-grade cannabis at considerably higher yields and greatly decreased costs. Hybrid aeroponics produces first-class cannabis quicker than traditional methods. In addition, it doesn’t necessitate natural sunlight or soil. Moreover, it can be operational and produce plants anywhere.
• The second level is processing, which focuses on staying as close to whole or organic as possible. Green Hygienics Holdings recently announced that it has executed an LOI with foremost CBD processor Coastal Labs LLC of Las Vegas, Nevada (http://ibn.fm/7z4Xr). Coastal Labs provides state-of-the-art extraction techniques and equipment for the cannabis industry. Furthermore, it provides wholesale distribution for clients looking to buy in bulk. With this acquisition of Coastal Labs, Green Hygienics is primed to add one of the leading labs in North America to its brand portfolio.
• The third level is dedicated to branding and brand acquisitions. The company suggests that interested parties visit its website and sign up to receive announcements.
• The fourth is Mad Marketing; there’s much more to come from this company!

Green Hygienics Holdings continues to advance its mission to provide consumers with high-quality and premium-grade cannabis products. For investors, the company’s dedication to growth through the creation of trusted international consumer brands offers the potential for significant return on investment. Green Hygienics is also working to grow in size and revenue by building a cultivation and extraction center in Canada, where legislation supports worldwide distribution.

For more information, visit the company’s website at www.GreenHygienicsHoldings.com

NOTE TO INVESTORS: The latest news and updates relating to GRYN are available in the company’s newsroom at http://ibn.fm/GRYN

• The biopesticides market is projected to grow at a CAGR of nearly 16 percent from 2018 to 2023
• Increasing adoption of organic farming is a key driver of biopesticide market growth, with the sector expected to reach $6.4 billion by 2023
• A patented natural biopesticide developed by MustGrow targets the fruit, vegetable, turf, ornamental and cannabis industries
• Net proceeds from the recent closing of $1.2 million in non-brokered private placements will help accelerate research and development efforts

Agricultural biotech company MustGrow Biologics Corp. is focused on developing and commercializing its patented technology – a natural biopesticide and biofertilizer. MustGrow’s technologies provide an all-natural, effective, safe and easy-to-use solution for farmers in the fruit, vegetable, turf and ornamental industries looking to raise healthy crops without the use of synthetic pesticides. Cannabis cultivators, working in the rapidly evolving cannabis space, are also potential agricultural partners.

The biopesticides market is projected to grow at a compound annual growth rate of 15.99 percent from 2018 to 2023, according to a new report issued by ResearchAndMarkets (http://ibn.fm/NLeEk). Growth of the biopesticides market is driven by advancements in integrated pest management solutions and increasing adoption of organic farming techniques, the March 2019 report states. Rising concerns about the harmful effects of chemical pesticides on the environment have encouraged the adoption of organic farming methods.

MustGrow’s natural biopesticides and biofertilizers, refined from compounds of the mustard plant, act as a nematicide (chemicals used to kill nematodes, or tiny, parasitic worms), a fungicide, a pesticide and a fertilizer (http://ibn.fm/DoyNi). Its technologies deliver first-rate pest and pathogen control in combination with plant growth and yield benefits available across a wide array of crops. MustGrow’s novel and proprietary solutions provide growers with a sustainable, beneficial technology that is user-friendly and superior to synthetic alternatives.

The company recently announced the closing of a non-brokered private placement that consisted of 1,712,533 MustGrow common shares, each priced at a $0.70 per share, for gross proceeds of $1,198,773 (http://ibn.fm/fpBsD). MustGrow intends to use the net proceeds to accelerate research and development of its biopesticide and biofertilizer formulations, as well as for working capital and general corporate purposes. The company plans to direct research and development proceeds toward its patented mustard-derived signature products and its prospective suite of in-licensed natural biologics.

The global economic impact of soil-borne nematodes is estimated at nearly $100 billion in lost crops per year. The American Phytopathological Society (http://ibn.fm/ro7A6), an international nonprofit scientific organization dedicated to the study and control of plant diseases, estimates that plant-pathogenic nematodes are responsible for 14 percent of crop losses worldwide.

MustGrow’s biopesticide has U.S. EPA (Environmental Protection Agency) and Canadian PMRA (Pest Management Regulatory Agency) labels and is an approved organic solution. To date, the company has completed more than 110 independent third-party field trials. MustGrow is at the forefront of development of unique solutions to help fruit, vegetable, turf, ornamental and cannabis growers control pests and crop diseases.

For more information, visit the company’s website at www.MustGrow.ca